News Daily News Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality Yael L. Maxwell December 12, 2024
News Daily News Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B Michael O'Riordan June 24, 2024
News Daily News FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy L.A. McKeown October 10, 2023
News Daily News Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy Michael O'Riordan May 06, 2019